The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-22
DOI
10.1038/s41598-021-92101-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report
- (2020) Grace E. Weber et al. JOURNAL OF IMMUNOLOGY
- Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
- (2020) William J. Meilandt et al. JOURNAL OF NEUROSCIENCE
- TREM2: Modulator of Lipid Metabolism in Microglia
- (2020) Eyiyemisi C. Damisah et al. NEURON
- Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer’s disease
- (2020) Tanusree Sen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
- (2020) Ling-Zhi Ma et al. Molecular Neurodegeneration
- Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
- (2020) Na Zhao et al. NEURON
- The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
- (2020) Aleksandra Deczkowska et al. CELL
- Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
- (2020) Michael Ewers et al. EMBO Molecular Medicine
- TREM2 ectodomain and its soluble form in Alzheimer’s disease
- (2020) Jiaolong Yang et al. Journal of Neuroinflammation
- Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
- (2020) Nicholas F. Fitz et al. Molecular Neurodegeneration
- Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
- (2020) Christiana Bjorkli et al. Frontiers in Aging Neuroscience
- Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
- (2019) Marc Suárez-Calvet et al. Molecular Neurodegeneration
- Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
- (2019) Jens Kuhle et al. NEUROLOGY
- TREM2 function impedes tau seeding in neuritic plaques
- (2019) Cheryl E. G. Leyns et al. NATURE NEUROSCIENCE
- TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
- (2019) Ana Griciuc et al. NEURON
- Role of TREM2 in Alzheimer's disease and its consequences on β-amyloid, Tau and neurofibrillary tangles
- (2019) Anurag Kumar Singh et al. Current Alzheimer Research
- Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
- (2019) Michael Ewers et al. Science Translational Medicine
- Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
- (2019) Nicholas J. Ashton et al. Alzheimers Research & Therapy
- CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults
- (2019) Nathalie Bodd Halaas et al. CEREBRAL CORTEX
- Microglia-Mediated Neuroprotection, TREM2 , and Alzheimer’s Disease: Evidence From Optical Imaging
- (2018) Carlo Condello et al. BIOLOGICAL PSYCHIATRY
- Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease
- (2018) M. Casati et al. EUROPEAN JOURNAL OF NEUROLOGY
- TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response
- (2018) Teng Jiang et al. INFLAMMATION
- Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
- (2018) L.M. Bekris et al. JOURNAL OF NEUROIMMUNOLOGY
- Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy
- (2018) Shu-Hui Xin et al. NEUROTOXICITY RESEARCH
- Increased Expression of TREM2 in Peripheral Blood of Alzheimer's Disease Patients
- (2018) Nan Hu et al. JOURNAL OF ALZHEIMERS DISEASE
- Soluble TREM2 changes during the clinical course of Alzheimer’s disease: A meta-analysis
- (2018) Dan Liu et al. NEUROSCIENCE LETTERS
- Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study
- (2018) Tomoyuki Ohara et al. ANNALS OF NEUROLOGY
- Microglia in Alzheimer’s disease
- (2017) David V. Hansen et al. JOURNAL OF CELL BIOLOGY
- Soluble TREM2 induces inflammatory responses and enhances microglial survival
- (2017) Li Zhong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Amyloid and Tau Pathology in Normal Cognitive Aging
- (2017) Emilie T. Reas JOURNAL OF NEUROSCIENCE
- Elucidating the Role of TREM2 in Alzheimer’s Disease
- (2017) Jason D. Ulrich et al. NEURON
- TREM2, Microglia, and Neurodegenerative Diseases
- (2017) Felix L. Yeh et al. TRENDS IN MOLECULAR MEDICINE
- Early-Versus Late-Onset Alzheimer's Disease: More than Age Alone
- (2017) Esther L.G.E. Koedam et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
- (2016) Laura Piccio et al. ACTA NEUROPATHOLOGICA
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
- (2016) Peng Yuan et al. NEURON
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
- (2016) Kristi Henjum et al. Alzheimers Research & Therapy
- TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
- (2015) Yaming Wang et al. CELL
- [18F]Florbetaben: A Review in β-Amyloid PET Imaging in Cognitive Impairment
- (2015) Yahiya Y. Syed et al. CNS DRUGS
- Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
- (2015) Yuka Atagi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Corrigendum: Solid-phase proximity ligation assays for individual or parallel protein analyses with readout via real-time PCR or sequencing
- (2015) Rachel Yuan Nong et al. Nature Protocols
- Tau aggregation and its interplay with amyloid-β
- (2014) Rebecca M. Nisbet et al. ACTA NEUROPATHOLOGICA
- Age-associated changes of cerebrospinal fluid amyloid-β and tau in cynomolgus monkeys
- (2014) Feng Yue et al. NEUROBIOLOGY OF AGING
- Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology
- (2013) M. Obulesu et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
- (2013) Benjamin Lam et al. Alzheimers Research & Therapy
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More